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1. Introduction 
Spectrin is the major protein of the red cell mem- 
brane cytoskeleton, a network, which covers the inner 
surface of the membrane and is responsible for main- 
taining the shape, stability and mechanical properties 
of the cell. The primary site of attachment of the 
cytoskeleton to the membrane is by way of an asso- 
ciation between spectrin and a receptor protein, 2.1 
or ankyrin [ 1,2], which is itself bound to the pre- 
ponderant transmembrane protein, band 3 [3,4]. The 
mechanism by which the cytoskeleton acts to control 
the membrane properties is not clear; some evidence 
has been adduced in favour of a direct interaction 
between spectrin and the lipid bilayer, and it has been 
suggested [S ,6] that this interaction stabilises the 
membrane and preserves the asymmetric distribution 
of the phospholipids between the inner and outer 
leaflet [7]. No direct binding studies with dispersed 
phospholipids have been carried out, probably due to 
the technical problems that such measurements 
present, but there are several reports [8--131 of 
perturbations in the properties of phospholipid vesi- 
cles, (all, however, by crude spectrin, contaminated 
with other cytoskeletal proteins) and one [ 141 of a 
relatively high propensity of spectrin to penetrate 
phospholipid monolayers. The observed effects have 
been reported to be greatest with phosphatidylserine 
[6,14], which is a component present exclusively in 
the inner leaflet of the membrane [7]. 
Spectrin, in terms of its amino acid composition 
and indeed its solubility properties, is by no means 
a particularly hydrophobic protein. For example the 
‘hydrophobicity index’, based on the free energies of 
transfer of the amino acid side chains from water to 
an organic solvent [ 151, is 880, which is similar to 
that of myosin and considerably lower than for 
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example those of actin, serum albumin and more 
especially of known integral membrane proteins. At 
the same time the technique of charge-shift electro- 
phoresis, using mixed detergent species [ 161, suggests 
that the structure of spectrin may embody a degree 
of amphiphilicity [ 171. Proton magnetic resonance, 
moreover, has shown that part of the protein is 
highly flexible in character, and markedly hydrophobic 
in composition [ 181. We show here, using a new group 
of hydrophobic model ligands which are strong 
quenchers of intrinsic protein fluorescence, that spec- 
trin contains a large number of binding sites for 
hydrocarbon chains, and infer the presence of inter- 
mittent hydrophobic regions along the molecule. 
2. Materials and methods 
Spectrin was prepared in the dimeric form by 
extraction of ghosts at low ionic strength at 3S’C 
for 10 min. In all other details the procedure was as 
in [ 191. The crude spectrin was purified by chroma- 
tography on Sepharose 4B and the dimer and oligomer 
were recovered, the latter containing also the cyto- 
skeletal proteins, actin and 4.1. Samples were screened 
for purity by sodium dodecyl sulphate (SDS)-poly- 
acrylamide gel electrophoresis. Protein concentrations 
were determined spectrophotometrically, taking the 
‘% specific absorptivity E, rm (280 nm) = 10.7 [20]. 
Fluorescence measurements were performed with a 
Perkin-Elmer Hitachi MPF3L spectrofluorimeter. 
The solvent was 0.1 M NaCl, 20 mM Tris (pH 8.0) 
except for the experiments at low ionic strength, and 
kept at 15’C. Protein solutions of absorbance 0.007- 
0.02 at the excitation wavelength (280 nm) were 
titrated with bromostearate or its homologues, dis- 
solved in ethanol. The final ethanol concentration did 
not exceed 5% (v/v). 
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The quenching agents used in this study were 
2-bromostearic acid and 9,10- and 17,18-dibromo- 
stearic acid. The latter were prepared by bromination 
with bromine in ether [2 l] of octadec-9-enoic (oleic) 
acid and octadec-17-enoic acid. The last was synthe- 
sised by Dr F. D. Gunstone [22] and the others were 
commercial samples. 
The brominated fatty acids are somewhat photo- 
chemically labile. Care was therefore taken to reduce 
the exposure of the solutions to ultraviolet light by 
minimising the entrance slit (which was generally 
2 nm) and the time of irradiation. Emission intensity 
was measured at 330 nm. For competition experi- 
ments, lysolecithins of different chain lengths (Sigma) 
were either added at fixed quencher concentration, 
or titrations with the quenchers were performed at 
fixed lysolecithin concentration. Egg phosphatidyl- 
choline was added when required after measurement 
of the fluorescent intensity in the presence of varying 
concentrations of 2-bromostearate. Critical micelle 
concentrations for the lysolecithins were checked by 
measurement of the change in fluorescent intensity 
of 1-anilino-8-naphthalene sulphonate with increasing 
lysolecithin concentrations [23]. 
3. Results 
2-Bromostearate was found to quench the intrinsic 
(tryptophan) fluorescence of spectrin with high eff- 
ciency. Because of the low (sub-mM) concentration 
range within which the effect was observed, the pro- 
cess is characterised as complex formation and not 
dynamic quenching. The concentration of the ligand 
throughout was below the self-association limit, and 
the temperature was well below the Krafft point. We 
cannot rule out the possibility that the solutions were 
supersaturated, but except where noted there was no 
detectable aggregation or precipitation: centrifuga- 
tion of the solution did not diminish the measured 
fluorescence, neither was there any significant change 
in the Rayleigh scattering intensity when the excita- 
tion and emission monochromators were set at the 
same wavelength. The non-aqueous solvent at the 
concentration added to the protein had no effect. A 
typical binding profile is shown in fig.1. This curve 
cannot be fitted in terms of one or a small number of 
very strong sites. In any case since the fluorescence 
comes from -70 tryptophan residues (determined 
spectrophotometrically in terms of the tryptophan: 
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Fig. 1. Fluorescence quenching curves for bromostearate bind- 
ing to spectrin dimers. Protein was 6.2 pg/ml and the sokent 
0.1 M NaCl, 20 mM Tris (pH 8.0). The curves are arbitrary 
binding profiles for 100 independent sites for 2-bromostearate/ 
dimer, each giving the same proportional degree of quenching, 
with the equilibrium constants indicated; (o) corresponding 
experimental points. 17,1%Dibromostearate (0); 9,10- 
dibromostearate (A). 
tyrosine ratio [24]) and some 60% of the fluorescence 
is quenched, such a model would scarcely be feasible. 
The system is too complex to justify any attempt at a 
detailed analysis of the number of sites and their dif- 
ferent affinities. However, as fig.1 indicates, a model 
involving a large number of comparable binding sites 
of moderate affinity (say 100 sitesldimer with associ- 
ation constants of the order of IO’--lo6 M-l) gives 
an adequate fit of the data. 
The binding is clearly predominantly hydrophobic 
because a 1 O-fold higher concentration of the shorter 
chain homologue, 2-bromomyristate, is required for 
comparable quenching, 2-bromopalmitate giving an 
intermediate effect, and 2-bromolaurate some 2 orders 
of magnitude lower quenching at the same concentra- 
tion. On the other hand at low ionic strength (5 mM 
NaCl, 1 mM Tris) there is perceptibly greater quench- 
ing, suggesting either a change in orientation of the 
bound l&and molecules or an increase in the number 
of binding sites, This may be due to the well-docu- 
mented expansion of the molecule at low ionic strength 
125,261 or to an increased degree of electrostatic 
interaction with the ligands. The quenching induced 
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by the 17 ,18-dibromostearate was an order of magni- 
tude lower than that by 2-bromostearate at the same 
concentration, the 9,10-isomer giving an intermediate 
effect. With increasing concentration of the 17 ,18- 
isomer there was a perceptible rise in Rayleigh scat- 
tering, due apparently to the formation of aggregates. 
To establish whether the lower quenching is due to a 
diminished efficiency of excitation deactivation or to 
weaker binding, competition experiments were per- 
formed. It was found that when equimolar amounts 
of 2-bromostearate and 17,18-dibromostearate were 
present the quenching was intermediate between the 
levels recorded with the 2 ligands separately, though 
closer to that induced by 2-bromostearate. Thus the 
binding of 2-bromostearate is stronger than that of 
17,18-dibromostearate but that when bound it is 
also a more efficient quencher. It may be inferred 
that the ends of the hydrocarbon chains bearing the 
carboxyl group are on average closer to tryptophan 
side chains than are the w-ends. 
Binding is substantially and rapidly reversible, for 
on addition of phosphatidylcholine vesicles the fluo- 
rescence returns to nearly its unperturbed value. It 
may be presumed that the bromostearate molecules 
are partitioning into the vesicles. However, we cannot 
rule out a degree of competition for sites on the 
spectrin. Phosphatidylserine vesicles have a similar 
effect. Attempts to achieve competition with mono- 
meric phospholipids did not give conclusive results 
because of the very low (e.g., 0.5 nM for egg phos- 
phatidylcholine [27]) critical micelle concentration 
of the phospholipid. Competition experiments were 
attempted with lauryllysophosphatidylcholine, which 
has a critical micelle concentration of 0.2 mM [28], 
working below this level. No significant competition 
was observed, showing that this molecule does not 
bind effectively at the hydrophobic sites. This may be 
partly a consequence of its relatively polar nature, 
but probably more particularly of the shorter chain 
length, which would rule out effective competition 
against the quencher at attainable monomer concen- 
trations. 
We note finally that the quenching profiles obtained 
for the oligomeric complex of spectrin, actin and 4.1 
were not significantly different from those for spectrin 
alone. This indicates that there is no significant occlu- 
sion of binding sites by the other proteins, which is in 
accord with expectation, since association occurs 
only at the ends of the elongated spectrin molecules. 
The weight proportion of spectrin in the complex is 
large [29], so that binding to actin or 4.1 would 
probably escape detection. 
4. Discussion 
The brominated fatty acids are clearly effective 
quenchers of indole fluorescence. They compete 
with fatty acids at hydrophobic binding sites. Bromo- 
stearate for example binds to bovine serum albumin 
with K, Z IO5 M-i (N. M. G., unpublished). 
The presence of a large number of hydrophobic 
binding sites on the spectrin molecule follows from 
the shape of the binding curves and also from the 
high degree of quenching: in a molecule 100 nm long 
[30], containing 70 tryptophan residues, that can col- 
lectively be quenched to >mO%, unless all the trypto- 
phans are clustered in a short segment of the chain the 
binding sites must be distributed along much of the 
total span. The location of bromines at the end of the 
chain remote from the polar group evidently not only 
reduces the efficiency of quenching by the bound 
ligand but also reduces its affinity for the binding 
sites. This may be due to the increase in dipolar 
character of the hydrocarbon, or more probably to 
some form of steric obstruction. The intermediate 
result obtained when the bromine atoms are in the 
middle of the chain suggests that much of the free 
energy of binding comes from the attachment of the 
part of the chain near the w-end. 
There is no justification for assuming that all sites 
are equivalent in affinity and structure, but a further 
argument in favour of spaced hydrophobic regions 
comes from proteolytic digestion experiments, which 
suggest the presence of a structural regularity in the 
molecule [31]. It may be noted that similarly abun- 
dant binding of a very different pair of ligands, 
haemin and protoporphyrin IX, to spectrin has been 
observed [32,33]. The segmentally flexible, hydro- 
phobic portion of the molecule giving rise to a sharp- 
line proton magnetic resonance spectrum [ 181 must 
thus be supposed to comprise a considerable number 
of short stretches of polypeptide chain, possibly those 
at which proteolysis most readily occurs to give a 
progression of fragments [3 11. If these all constitute 
relatively weak sites of interaction with lipid, at 
which the chain can penetrate into the bilayer, such a 
disposition could more readily explain how the net- 
work of filamentous molecules over the membrane 
surface might have a large effect on the stability of 
111 
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the bilayer as has been suggested [5,6], while at the 
same time dissociating rather readily under conditions 
in which the primary binding interaction with protein 
2.1, or ankyrin is weakened [ 1,2]. 
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